Evidence map›Paper›PMID 29053802›Full record

ArticleThe Journal of clinical endocrinology and metabolism2017

Docosahexaenoic Acid Supplementation in Pregnancy Modulates Placental Cellular Signaling and Nutrient Transport Capacity in Obese Women.

Susanne Lager, Vanessa I Ramirez, Ometeotl Acosta, Christiane Meireles, Evelyn Miller, Francesca Gaccioli, Fredrick J Rosario, Jonathan A L Gelfond, Kevin Hakala, Susan T Weintraub and 2 more

Open access · bronzeAbstract read
In one paragraph

Article in The Journal of clinical endocrinology and metabolism, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed, 2 pooled it
2.6field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 2 syntheses or guidelines pooled it, 36 citations in OpenAlex.

  1. Pooled it
  2. Omega-3 fatty acid addition during pregnancy.The Cochrane database of systematic reviews · 2018
    Pooled it
  3. Trial
  4. MaternalNutrients · 2026
    Review
  5. Review
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Role of Placental Glucose Transporters in Determining Fetal Growth.Reproductive sciences (Thousand Oaks, Calif.) · 2022
    Review
  14. Review
  15. Review
  16. Article
  17. Review
  18. Review
  19. Endometrial Decidualization: The Primary Driver of Pregnancy Health.International journal of molecular sciences · 2020
    Review
  20. Placental function in maternal obesity.Clinical science (London, England : 1979) · 2020
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 4 institutions in 3 countries.

Susanne LagerDepartment of Obstetrics and Gynaecology, University of Cambridge, United Kingdom.
Vanessa I RamirezDepartment of Obstetrics and Gynecology, University of Texas Health Science Center.
Ometeotl AcostaDepartment of Obstetrics and Gynecology, University of Texas Health Science Center.
Christiane MeirelesDepartment of Obstetrics and Gynecology, University of Texas Health Science Center.
Evelyn MillerDepartment of Obstetrics and Gynecology, University of Texas Health Science Center.
Francesca GaccioliDepartment of Obstetrics and Gynaecology, University of Cambridge, United Kingdom.
Fredrick J RosarioDivision of Reproductive Sciences, Department of Obstetrics and Gynecology, University of Colorado Anschutz Medical Campus.
Jonathan A L GelfondDepartment of Epidemiology and Biostatistics, University of Texas Health Science Center.
Kevin HakalaDepartment of Biochemistry, University of Texas Health Science Center.
Susan T WeintraubDepartment of Biochemistry, University of Texas Health Science Center.
Debra A KrummelDepartment of Nutrition Sciences, University of Cincinnati.
Theresa L PowellDivision of Reproductive Sciences, Department of Obstetrics and Gynecology, University of Colorado Anschutz Medical Campus.
The University of Texas Health Science Center at San Antonio · USUniversity of Cambridge · GBUniversity of Colorado Anschutz Medical Campus · USUniversity of Cincinnati · US

Funding

PILOT STUDY--SUBSTRATE METABOLISM IN EXTREMELY LOW BIRTH WEIGHT INFANTSP30DK048520 · NIDDK · UNIVERSITY OF COLORADO DENVER · PI Wendy M Kohrt · 1995 to 2026
$32.6M
Institute for Integration of Medicine & Science: A Partnership to Improve HealthUL1TR001120 · NCATS · UNIVERSITY OF TEXAS HLTH SCIENCE CENTER · PI CLARK, ROBERT A, HARGREAVES, KENNETH M · 2013 to 2017
$16.5M
Institute for Integration of Medicine & Science: A Partnership to Improve HealthUL1TR000149 · NCATS · UNIVERSITY OF TEXAS HLTH SCIENCE CENTER · PI CLARK, ROBERT A · 2012 to 2013
$6.8M
DHA, Inflammation, and Insulin Sensitivity in Obese Pregnant WomenR21HL093532 · NHLBI · UNIVERSITY OF CINCINNATI · PI KRUMMEL, DEBRA ANN · 2008 to 2009
$638k
NCATS NIH HHS UL1 TR000149NCATS NIH HHS UL1 TR001120NHLBI NIH HHS R21 HL093532NIDDK NIH HHS P30 DK048520
6 · The paper itself

Abstract

Context: Maternal obesity in pregnancy has profound impacts on maternal metabolism and promotes placental nutrient transport, which may contribute to fetal overgrowth in these pregnancies. The fatty acid docosahexaenoic acid (DHA) has bioactive properties that may improve outcomes in obese pregnant women by modulating placental function. Objective: To determine the effects of DHA supplementation in obese pregnant women on maternal metabolism and placental function. Design: Pregnant women were supplemented with DHA or placebo. Maternal fasting blood was collected at 26 and 36 weeks' gestation, and placentas were collected at term. Setting: Academic health care institution. Subjects: Thirty-eight pregnant women with pregravid body mass index ≥30 kg/m2. Intervention: DHA (800 mg, algal oil) or placebo (corn/soy oil) daily from 26 weeks to term. Main Outcomes: DHA content of maternal erythrocyte and placental membranes, maternal fasting blood glucose, cytokines, metabolic hormones, and circulating lipids were determined. Insulin, mTOR, and inflammatory signaling were assessed in placental homogenates, and nutrient transport capacity was determined in isolated syncytiotrophoblast plasma membranes. Results: DHA supplementation increased erythrocyte (P < 0.0001) and placental membrane DHA levels (P < 0.0001) but did not influence maternal inflammatory status, insulin sensitivity, or lipids. DHA supplementation decreased placental inflammation, amino acid transporter expression, and activity (P < 0.01) and increased placental protein expression of fatty acid transporting protein 4 (P < 0.05). Conclusions: Maternal DHA supplementation in pregnancy decreases placental inflammation and differentially modulates placental nutrient transport capacity and may mitigate adverse effects of maternal obesity on placental function.

Indexed as

Dietary SupplementsAdultBlood GlucoseCarrier ProteinsCytokinesDocosahexaenoic AcidsFatty AcidsFemaleFetal DevelopmentHormonesHumansInfant, NewbornLipidsObesityPlacentaPregnancyBlood GlucoseCarrier ProteinsCytokinesDocosahexaenoic AcidsFatty AcidsHormonesLipids

Identifiers

PMID29053802
PMCPMC5718695
OpenAlexW2765742251

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.